Inflammation as a Clinical Endpoint in CKM: Are We There Yet?, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how inflammation is being evaluated across cardiovascular-kidney-metabolic (CKM) disease as a therapeutic target, biomarker and potential clinical endpoint. The featured speakers will discuss evidence linking inflammation with metabolic, cardiovascular and kidney disease, along with the challenges of translating this biology into measurable endpoints. Attendees will also explore what emerging evidence could mean for trial design, patient selection and biomarker strategies in CKM clinical development.

TORONTO, Oct. 1, 2026 /PRNewswire/ -- As understanding of cardiovascular-kidney-metabolic (CKM) syndrome evolves, inflammation has emerged as a compelling biological thread connecting disease progression across the heart, kidneys and metabolic system. A long-standing question for the field is resurfacing: does chronic systemic inflammation drive disease progression across the CKM spectrum, or has the science outpaced the clinical evidence?

This evolving science raises important questions for clinicians, researchers and industry stakeholders that this webinar will explore: Should inflammation be considered a distinct therapeutic target in CKM? Could it serve as a meaningful clinical endpoint?

The featured speakers will address the specific challenges involved in translating mechanistic understanding into a validated clinical endpoint, including how emerging evidence is reshaping the understanding of this "silent" and often underrecognized driver of disease.

Emerging evidence points to a plausible progression suggesting inflammation may act as a connective thread running through diseases, from obesity to insulin resistance, to vascular inflammation, to kidney dysfunction, to heart failure, that have traditionally been managed as separate, organ-specific concerns. The experts will walk through this proposed pathway and examine why inflammation is increasingly viewed as a cross-system process rather than an isolated biological mechanism.

Attendees will hear how researchers and clinicians are approaching the assessment of inflammation in CKM patients today, including which biomarkers and immune mechanisms are being explored and the specific obstacles that have made inflammation so difficult to translate into a validated, measurable clinical endpoint.

As healthcare moves toward more integrated models of care, this webinar will examine what the current evidence means for trial design, patient selection, biomarkers and endpoint strategy across cardiovascular, renal and metabolic diseases.

The goal is to help development leaders assess where inflammation is actionable today, where evidence remains insufficient and what advances could change its role in CKM clinical development.

Register for this webinar to learn how CKM research is evaluating inflammation as a therapeutic target, biomarker and potential clinical endpoint.

Join experts from Syneos Health, Anup Sabharwal, MD, MBA, FACC, FACE, FESC, FAHA, FASPC, FNLA, Head of Research & Development, Cardiovascular-Kidney-Metabolic; James Snyder, MD, Medical Strategist, Medical Management, Cardiovascular-Kidney-Metabolic; and Tristan Baldwinson, Therapeutic Area Head, Cardiovascular-Kidney-Metabolic, for the live webinar on Monday, October 19, 2026, at 11am EDT (5pm CEST / EU-Central).

For more information, or to register for this event, visit Inflammation as a Clinical Endpoint in CKM: Are We There Yet?.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks